HUTCHMED (China) Limited (0013.HK) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close21.880

Open21.900

Day range21.90023.460

52-week range15.57025.580

Off day high−2.30%

Off 52-week high−10.40%

Volume6.96M

Avg. volume (3M)5.63M

Market cap19.92B

EPS (TTM)0.1600

Forward P/E33.76

P/E ratio (TTM)143.25

Dividend yield—

Beta (5Y)0.49

Shares outstanding869.07M

Short interest—

Earnings dateJul 30, 2026

Analyst target32.692

Profit margin3.26%

Against its peers

Compare in full ›

	0013.HK	300558.SZ	688321.SS	2096.HK	6998.HK	GUD.TO
Market cap	19.92B	20.76B	9.47B	28.55B	3.11B	1.11B
P/E (TTM)	143.3	77.9	133.7	16.4	9.9	75.3
Forward P/E	33.8	29.2	-107.0	12.1	-1.9	43.5
Price/book	2.0	3.2	3.7	2.6	0.7	1.4
Dividend yield	—	0.31%	0.28%	1.92%	—	—
1-year change	−9.66%	−11.61%	−31.78%	−16.58%	−45.69%	+86.16%
Today	+4.75%	+1.62%	+2.84%	+3.71%	+0.32%	+0.36%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to HUTCHMED (China)'s by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Betta Pharmaceuticals Co., Ltd.300558.SZ · Drug Manufacturers - Specialty & Generic	20.76B	49.05	+1.62%
Shenzhen Chipscreen Biosciences Co., Ltd.688321.SS · Drug Manufacturers - Specialty & Generic	9.47B	21.39	+2.84%
Simcere Pharmaceutical Group Limited2096.HK · Drug Manufacturers - Specialty & Generic	28.55B	11.170	+3.71%
Edding Genor Group Holdings Limited6998.HK · Drug Manufacturers - Specialty & Generic	3.11B	1.580	+0.32%
Knight Therapeutics Inc.GUD.TO · Drug Manufacturers - Specialty & Generic	1.11B	11.30	+0.36%
RemeGen Co., Ltd.9995.HK · Biotechnology	40.23B	71.300	+1.49%
CStone Pharmaceuticals2616.HK · Biotechnology	8.98B	5.635	+4.16%
InventisBio Co., Limited688382.SS · Biotechnology	8.38B	14.45	+4.33%

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company	Mkt cap	Price	Today
Venus Remedies LimitedVENUSREM.BO · Panchkula, India	19.44B	1,454.15	+5.00%
Fuso Pharmaceutical Industries,Ltd.4538.T · Osaka, Japan	18.37B	2,152.00	+2.77%
Syncom Formulations (India) LimitedSYNCOMF.NS · Indore, India	19.75B	21.01	+2.19%
Pharma Foods International Co., Ltd.2929.T · Kyoto, Japan	17.14B	590.00	−0.17%
CanSino Biologics Inc.688185.SS · Tianjin, China	19.39B	78.47	+10.21%
Windlas Biotech LimitedWINDLAS.NS · Dehradun, India	19.01B	921.25	+5.47%
Kangmei Pharmaceutical Co., Ltd.600518.SS · Shenzhen, China	18.95B	1.3700	−1.44%
Walvax Biotechnology Co., Ltd.300142.SZ · Kunming, China	18.70B	11.69	+2.19%

Healthcare companies of a similar market value (18.01B).

Company	Mkt cap	Price	Today
Venus Remedies LimitedVENUSREM.BO · Drug Manufacturers - Specialty & Generic	19.44B	1,454.15	+5.00%
Fuso Pharmaceutical Industries,Ltd.4538.T · Drug Manufacturers - Specialty & Generic	18.37B	2,152.00	+2.77%
Syncom Formulations (India) LimitedSYNCOMF.NS · Drug Manufacturers - Specialty & Generic	19.75B	21.01	+2.19%
Pharma Foods International Co., Ltd.2929.T · Drug Manufacturers - Specialty & Generic	17.14B	590.00	−0.17%
CanSino Biologics Inc.688185.SS · Drug Manufacturers - Specialty & Generic	19.39B	78.47	+10.21%
Winner Medical Co., Ltd.300888.SZ · Medical Instruments & Supplies	17.92B	30.74	+0.46%
Windlas Biotech LimitedWINDLAS.NS · Drug Manufacturers - Specialty & Generic	19.01B	921.25	+5.47%
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.300255.SZ · Biotechnology	18.94B	20.61	+3.15%

Also based in Hong Kong, Hong Kong, then elsewhere in Hong Kong.

Company	Mkt cap	Price	Today
CNOOC Limited0883.HK · Hong Kong, Hong Kong	1.11T	23.280	−2.10%
Swire Properties LimitedSW9.F · Hong Kong, Hong Kong	17.50B	3.0400	+5.56%
Kunlun Energy Company LimitedCTJ1.F · Hong Kong, Hong Kong	7.28B	0.8450	−1.74%
HK Electric Investments and HK Electric Investments LimitedHKT.F · Hong Kong, Hong Kong	6.14B	0.6950	+0.72%
China Everbright Environment Group LimitedCNE.F · Hong Kong, Hong Kong	3.34B	0.5440	+1.12%
InSilico Medicine Cayman TopCoO15.F · Hong Kong, Hong Kong	2.54B	4.3800	0.00%
China Overseas Property Holdings Limited2669.HK · Hong Kong, Hong Kong	11.05B	3.365	+1.82%
China Overseas Grand Oceans Group Limited0081.HK · Hong Kong, Hong Kong	10.46B	2.940	+3.52%

The stocks whose daily moves over the past year went most closely with HUTCHMED (China)'s: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
InnoCare Pharma Limited9969.HK · Correlation 0.59	21.56B	12.200	+1.33%
Shanghai Junshi Biosciences Co., Ltd.1877.HK · Correlation 0.56	16.34B	15.930	+1.53%
Hansoh Pharmaceutical Group Company Limited3692.HK · Correlation 0.53	213.29B	35.180	+3.11%
Simcere Pharmaceutical Group Limited2096.HK · Correlation 0.52	28.55B	11.170	+3.71%
Zai Lab Limited9688.HK · Correlation 0.44	22.56B	18.170	+0.89%
Livzon Pharmaceutical Group Inc.1513.HK · Correlation 0.41	21.49B	24.200	+0.50%
Jiangsu Yahong Meditech Co., Ltd.688176.SS · Correlation 0.40	6.69B	11.70	+4.46%
Tasly Pharmaceutical Group Co., Ltd600535.SS · Correlation 0.39	21.57B	14.44	+0.70%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 0013.HK news ›

MarketScreener·2d agoPositive

Hutchmed China hails Orpathys acceptance for review in Japan and EU

Published on 11/02/2026 at 09:27 am EST (Alliance News) - Hutchmed China Ltd on Monday said regulatory filings for Orpathys, alias savolitinib, in combination with Tagrisso have been accepted for review in Japan and the EU. The Hong…

AZN JHPCY NVO

markets.businessinsider.com·Oct 28Positive

CICC Remains a Buy on HUTCHMED (China) (HCM)

CICC analyst maintained a Buy rating on HUTCHMED (China) yesterday and set a price target of HK$28.00. The company’s shares closed yesterday a... CICC analyst maintained a Buy rating on HUTCHMED (China) yesterday and set a price target of…

HCM HUT CRC HCPC

MarketScreener·Oct 21

Hutchmed (China) Closes Licensing Deal with GSK for Drug Candidate HMPL-A830

Published on 10/20/2026 at 11:53 pm EDT Berenberg still a buyer of GSK, considering stock undervalued October 14, 2026 at 10:33 am EDT GSK plc: Priced for the storm, being built for thereafter GSK: shareholders urge company to step up…

MRK NVO AZN GSK

TradingView·Oct 20

Hutchmed (China) Closes Exclusive Development And License Agreement With GSK Unit

TradingView Hutchmed (China) Closes Exclusive Development And License Agreement With GSK Unit

NVS GSK

MarketBeat·Oct 13Negative

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Stock Rated "Moderate Buy" by Sell-Side Brokerages

Check Out Our Latest Stock Report on HUTCHMED HCM stock opened at $13.68 on Tuesday. The company's 50-day moving average price is $13.22 and its two-hundred day moving average price is $12.65. The company has a debt-to-equity ratio of…

HUT

From the 4Search news index, newest first.

In the news

5mentions in 30 days

5with it in the headline

Positivesentiment

Most coverage from

marketscreener.com2
marketbeat.com1
markets.businessinsider.com1
tradingview.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.